The Firmwatch take
Huma Therapeutics Limited (07725451) currently shows: No major warning signs in the latest extracted accounts, based on accounts to 31 December 2024; last refreshed 24 May 2026. No distress signals. Accounts cover the period ending 31 Dec 2024.
Companies House source·Accounts to 31 Dec 2024·Refreshed 24 May 2026·Methodology and caveats
Firmwatch signals are generated from public filings and are not credit ratings or financial advice.
Incorporated
2 August 2011
14 years on the register
Sector
Other telecommunications activities
SIC 61900
Size
Not classified
Net assets
£104m
Top 10% in sector
Cash at bank
Not disclosed
Not required for this filing type
Latest filing
None yet
Insolvency risk
Low insolvency risk
The latest public accounts do not show obvious balance-sheet stress. This does not rule out trading problems, but the filed numbers look comparatively steady.
Positive net assets
The latest extracted accounts show assets exceeding liabilities.
Sector benchmark · Telecoms
How this company compares in 6,682 telecoms firms
Top 10% in sector — Huma Therapeutics Limited shows £104m in net assets. Sector median is £3k.
Sector medians are computed annually across all UK companies in this broad sector. Position is approximate — see the Money tab for the full balance sheet.
Address pattern · SW1P 4QP
332 other UK companies registered at this postcode.
Active
320
Dissolved
3
Strike-off action
7
Money
What the balance sheet says
Net assets
£104m
Top 10% in sector · sector median £3k · 6,682 telecoms firms
Cash
Not disclosed
Working cap.
£47m
Median £8k
Current ratio
5.4×
Median 1.3×
Signals · 1
Positive net assets
The latest filed accounts show assets exceeding liabilities.
Firmwatch turns UK Companies House filings into plain-English company intelligence. Data is refreshed daily; signals are generated from public balance-sheet and filing patterns.